Viracta Therapeutics

Viracta is committed to advancing new medicines based on its viral activation therapy approach to benefit patients.

Launch date

Nov 2016

Employees

Market cap

Net debt

-

Enterprise valuation

$9m (Public information from May 2024)

Encinitas California (HQ)

http://viracta.com

https://twitter.com/viractat https://www.linkedin.com/company/viracta-therapeutics-inc./

View job openings

Deals in current and previous year:

Sunesis Pharmaceuticals

Authorizing premium user...